Ruzaeva L A, Ol'khovskiĭ I A, Neshumaev D A, Shevchenko N M, Vinogradova M N
Zh Mikrobiol Epidemiol Immunobiol. 2008 Nov-Dec(6):19-22.
To evaluate diagnostic value of p24 antigen detection for algorithm of confirmatory diagnostics of HIV-infection.
Concurrently with Western blot assay (WB, "New Lav Blot1", Bio-Rad), tests for detection of p24 antigen of HIV (Genetic Systems HIV-1 Ag EIA", "VectoHIV-1 p24-antigen confirming test", and "DS-EIA-HIV-AG-SCREEN") were used for confirmation of first-positive result of immuno-enzyme assay.
p24 HIV antigen was detected in serum samples in 8.4% of patients with equivocal result of WB and in 4.2% of patients with negative and positive results of WB. Presence of p24 was correlated with high viral load, and, in patients with confirmed diagnosis, with low CD4 cells count (<500 cells/ml). p24 was detected in more than 30% of persons with confirmed seroconversion after primary testing.
In groups of persons with negative and equivocal results of WB assay, detection of HIV p24 antigen points to the presence of infection and could be the reason for the final diagnosis. Detection of p24 in patients with positive result of WB assay allows to consider them as probable candidates for highly active antiretroviral therapy.
评估p24抗原检测在人类免疫缺陷病毒(HIV)感染确证诊断流程中的诊断价值。
在进行蛋白质印迹法检测(WB,“New Lav Blot1”,伯乐公司)的同时,采用检测HIV p24抗原的试验(“基因系统HIV-1抗原酶免疫测定法”、“VectoHIV-1 p24抗原确证试验”以及“DS-EIA-HIV-AG-SCREEN”)来确证免疫酶测定法的首次阳性结果。
在WB结果不明确的患者血清样本中,8.4%检测到p24 HIV抗原;在WB结果为阴性和阳性的患者中,4.2%检测到该抗原。p24的存在与高病毒载量相关,在确诊患者中,与低CD4细胞计数(<500个细胞/毫升)相关。在初次检测后确诊血清转换的人群中,超过30%检测到p24。
在WB检测结果为阴性和不明确的人群中,检测HIV p24抗原表明存在感染,可能是最终诊断的依据。在WB检测结果为阳性的患者中检测到p24,可将其视为高效抗逆转录病毒治疗的可能候选者。